Funding opportunities
363 live opportunities from Grants.gov, NIH, NSF, and more.
Engineering× remove
- Molecular Mechanisms of CbrA Transceptor Signaling in PseudomonasNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $413,092activenih
- Augmented-reality guided lumpectomyNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $395,973activenih
- A practical, clinically-focused endovascular cooling system for neuroprotection in acute ischemic strokeNational Institute of Neurological Disorders and StrokePA-25-150 closes 5/31/2028up to $443,850activenih
- Preclinical Pluripotent Stem Cell Investigation for Vascular TherapeuticsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $335,917activenih
- Engineering a Human Glial-Neuronal Microphysiological System to Study Myelination and Axonal-Synaptic Pathology in Alzheimer's DiseaseNational Institute on AgingPAR-25-199 closes 5/31/2028up to $486,750activenih
- Role of the DEAH-Box RNA helicase DHX29 during Class Switch Recombination in B-cellsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $195,625activenih
- Understanding how environmental microbiomes shape animal sensationNational Institute of General Medical SciencesPA-24-194 closes 5/31/2028up to $125,000activenih
- Harnessing in-tissue antibodies for therapeutic HSV controlNational Institute of Allergy and Infectious DiseasesRFA-AI-24-068 closes 5/31/2028up to $238,899activenih
- Multifaceted Immunomodulatory Self-Healing Glue for Treatment of Chronic WoundsNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-304 closes 5/31/2028up to $368,156activenih
- Development of methods for robust gene integration into native gut E. coliNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $438,625activenih
- Pathways and Mechanisms of Drug Resistance Evolution in HIVNational Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $161,868activenih
- A general method for converting antibodies into fluorescent sensors of their antigensNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $405,202activenih
- Use of scnn1b transgenic mice to develop new vaccines against pulmonary Mycobacterium aviumNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $423,500activenih
- Targeting post-fusion influenza hemagglutinin to make a better flu vaccineNational Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $160,609activenih
- Integrated fatty acid profiling unveils a linkage between BMI and efficacy of anti-tumor immunotherapyNational Cancer InstitutePAR-25-135 closes 5/31/2028up to $129,285activenih
- Addressing C-F bonds and amyloid-formation in biological systemsNational Institute of Neurological Disorders and StrokePA-25-302 closes 5/31/2028up to $138,730activenih
- Elucidating the mechanical regulation of the lung gas exchange interfaceNational Heart Lung and Blood InstitutePA-24-194 closes 5/31/2028up to $157,658activenih
- Characterization of Structural Polymorphism in Native Murine Polyomavirus from Mouse CellsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $222,457activenih
- Herpes Simplex Immunotherapeutic Targeting CD8 T cellsNational Institute of Allergy and Infectious DiseasesRFA-AI-24-068 closes 5/31/2028up to $256,074activenih
- Surface EMG-driven home exercise program for postoperative rehabilitation after peripheral nerve injuriesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPAR-25-124 closes 5/31/2028up to $324,875activenih
- Developing Cross Protective Vaccine to Control Leptospira InfectionNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $200,233activenih
- Engineering broadly cross-reactive monobodies to reverse botulinum intoxicationNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $501,137activenih
- Engineering inducible morphotype switching control in Mycobacterium abscessus for investigating infection outcomes and discovering pathophysiological-targeted treatmentsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $429,997activenih
- Next Generation pan-serotype,antitoxin for botulinum neurotoxin exposuresNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $531,688activenih
- Developing a 3D bioprinted bone marrow model to probe hematopoietic stem cell mobilization in response to age-related changes in stiffness gradientsNational Heart Lung and Blood InstitutePA-23-272 closes 5/31/2028up to $49,917activenih